The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((4-((1S,4S)-4-Aminocyclohexyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile ID: ALA4861464
PubChem CID: 150098152
Max Phase: Preclinical
Molecular Formula: C17H18F3N7
Molecular Weight: 377.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(Nc2ncc(C(F)(F)F)c(N[C@H]3CC[C@@H](N)CC3)n2)cn1
Standard InChI: InChI=1S/C17H18F3N7/c18-17(19,20)14-9-24-16(26-13-6-5-12(7-21)23-8-13)27-15(14)25-11-3-1-10(22)2-4-11/h5-6,8-11H,1-4,22H2,(H2,24,25,26,27)/t10-,11+
Standard InChI Key: DURGJOGRWTUVSP-PHIMTYICSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
31.9954 -4.0333 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.4120 -3.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5866 -3.3162 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.1272 -3.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1260 -4.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8409 -4.9735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5573 -4.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5544 -3.7254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8391 -3.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2724 -4.9715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9863 -4.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6980 -4.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4113 -4.5526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.4104 -3.7267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6903 -3.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9799 -3.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4125 -2.4959 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.8366 -2.4955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5498 -2.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1205 -3.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8339 -2.8998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2690 -2.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9801 -2.0772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9804 -1.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2633 -0.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5460 -1.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6903 -0.8414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
4 2 1 0
2 17 1 0
9 18 1 0
19 18 1 1
20 21 3 0
14 20 1 0
19 22 1 0
19 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.37Molecular Weight (Monoisotopic): 377.1576AlogP: 3.19#Rotatable Bonds: 4Polar Surface Area: 112.54Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.41CX Basic pKa: 9.99CX LogP: 1.75CX LogD: -0.30Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -1.48
References 1. Jin T, Xu L, Wang P, Hu X, Zhang R, Wu Z, Du W, Kan W, Li K, Wang C, Zhou Y, Li J, Liu T.. (2021) Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile., 64 (20.0): [PMID:34665631 ] [10.1021/acs.jmedchem.1c00994 ]